Indini, A.; Rijavec, E.; Ghidini, M.; Cortellini, A.; Grossi, F.
Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors. Pharmaceutics 2021, 13, 653.
https://doi.org/10.3390/pharmaceutics13050653
AMA Style
Indini A, Rijavec E, Ghidini M, Cortellini A, Grossi F.
Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors. Pharmaceutics. 2021; 13(5):653.
https://doi.org/10.3390/pharmaceutics13050653
Chicago/Turabian Style
Indini, Alice, Erika Rijavec, Michele Ghidini, Alessio Cortellini, and Francesco Grossi.
2021. "Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors" Pharmaceutics 13, no. 5: 653.
https://doi.org/10.3390/pharmaceutics13050653
APA Style
Indini, A., Rijavec, E., Ghidini, M., Cortellini, A., & Grossi, F.
(2021). Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors. Pharmaceutics, 13(5), 653.
https://doi.org/10.3390/pharmaceutics13050653